Abstract
Sorafenib, an oral small molecule multikinase inhibitor indicated for the treatment of some solid tumors, has been associated with a variety of cutaneous adverse events. Erythema multiforme is one of the extremely rare skin toxicities reported. We present this interesting case to show and discuss the cutaneous side effects of sorafenib, in particular the erythema multiforme that occurred in a woman treated for metastatic hepatocellular cancer after only five days of treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
